501 related articles for article (PubMed ID: 9852924)
1. Nonthrombogenic, adhesive cellular lining for left ventricular assist devices.
Scott-Burden T; Tock CL; Bosely JP; Clubb FJ; Parnis SM; Schwarz JJ; Engler DA; Frazier OH; Casscells SW
Circulation; 1998 Nov; 98(19 Suppl):II339-45. PubMed ID: 9852924
[TBL] [Abstract][Full Text] [Related]
2. Genetically engineered smooth muscle cells as linings to improve the biocompatibility of cardiovascular prostheses.
Scott-Burden T; Tock CL; Schwarz JJ; Casscells SW; Engler DA
Circulation; 1996 Nov; 94(9 Suppl):II235-8. PubMed ID: 8901752
[TBL] [Abstract][Full Text] [Related]
3. A genetically engineered, nonthrombogenic cellular lining for LVADs: in vitro preconditioning before in vivo implantation.
Tock CL; Bosley JP; Parnis SM; Clubb FJ; Macris MP; Frazier OH; Scott-Burden T
ASAIO J; 1999; 45(3):172-7. PubMed ID: 10360718
[TBL] [Abstract][Full Text] [Related]
4. Pathological sequelae of implantation of intracorporeal left ventricular assist devices in the calf.
Coumbe A; Keefe MB; Salih V; Reynolds PS; Graham TR; Berry CL
Am J Cardiovasc Pathol; 1993; 4(4):302-16. PubMed ID: 8305193
[TBL] [Abstract][Full Text] [Related]
5. Use of autologous auricular chondrocytes for lining artificial surfaces: a feasibility study.
Scott-Burden T; Bosley JP; Rosenstrauch D; Henderson KD; Clubb FJ; Eichstaedt HC; Eya K; Gregoric I; Myers TJ; Radovancevic B; Frazier OH
Ann Thorac Surg; 2002 May; 73(5):1528-33. PubMed ID: 12022544
[TBL] [Abstract][Full Text] [Related]
6. Development of an artificial vessel lined with human vascular cells.
Gulbins H; Dauner M; Petzold R; Goldemund A; Anderson I; Doser M; Meiser B; Reichart B
J Thorac Cardiovasc Surg; 2004 Sep; 128(3):372-7. PubMed ID: 15354094
[TBL] [Abstract][Full Text] [Related]
7. Micropatterned polymer surfaces improve retention of endothelial cells exposed to flow-induced shear stress.
Daxini SC; Nichol JW; Sieminski AL; Smith G; Gooch KJ; Shastri VP
Biorheology; 2006; 43(1):45-55. PubMed ID: 16627926
[TBL] [Abstract][Full Text] [Related]
8. Shear-stress preconditioning and tissue-engineering-based paradigms for generating arterial substitutes.
Baguneid M; Murray D; Salacinski HJ; Fuller B; Hamilton G; Walker M; Seifalian AM
Biotechnol Appl Biochem; 2004 Apr; 39(Pt 2):151-7. PubMed ID: 15032735
[TBL] [Abstract][Full Text] [Related]
9. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
[TBL] [Abstract][Full Text] [Related]
10. A low-flow adaptation phase improves shear-stress resistance of artificially seeded endothelial cells.
Gulbins H; Pritisanac A; Petzold R; Goldemund A; Doser M; Dauner M; Meiser B; Reichart B; Daebritz S
Thorac Cardiovasc Surg; 2005 Apr; 53(2):96-102. PubMed ID: 15786008
[TBL] [Abstract][Full Text] [Related]
11. Low thromboembolic risk for patients with the Heartmate II left ventricular assist device.
John R; Kamdar F; Liao K; Colvin-Adams M; Miller L; Joyce L; Boyle A
J Thorac Cardiovasc Surg; 2008 Nov; 136(5):1318-23. PubMed ID: 19026822
[TBL] [Abstract][Full Text] [Related]
12. Effects of centrifugal, axial, and pulsatile left ventricular assist device support on end-organ function in heart failure patients.
Kamdar F; Boyle A; Liao K; Colvin-adams M; Joyce L; John R
J Heart Lung Transplant; 2009 Apr; 28(4):352-9. PubMed ID: 19332262
[TBL] [Abstract][Full Text] [Related]
13. Mechano-active tissue engineering of vascular smooth muscle using pulsatile perfusion bioreactors and elastic PLCL scaffolds.
Jeong SI; Kwon JH; Lim JI; Cho SW; Jung Y; Sung WJ; Kim SH; Kim YH; Lee YM; Kim BS; Choi CY; Kim SJ
Biomaterials; 2005 Apr; 26(12):1405-11. PubMed ID: 15482828
[TBL] [Abstract][Full Text] [Related]
14. Cyclic flexure and laminar flow synergistically accelerate mesenchymal stem cell-mediated engineered tissue formation: Implications for engineered heart valve tissues.
Engelmayr GC; Sales VL; Mayer JE; Sacks MS
Biomaterials; 2006 Dec; 27(36):6083-95. PubMed ID: 16930686
[TBL] [Abstract][Full Text] [Related]
15. The lining of textured surfaces in implantable left ventricular assist devices. An immunocytochemical and electronmicroscopic study.
Salih V; Graham TR; Berry CL; Coumbe A; Smith SC; Dasse K; Frazier OH
Am J Cardiovasc Pathol; 1993; 4(4):317-25. PubMed ID: 8305194
[TBL] [Abstract][Full Text] [Related]
16. Activation of endothelial and coagulation systems in left ventricular assist device recipients.
John R; Panch S; Hrabe J; Wei P; Solovey A; Joyce L; Hebbel R
Ann Thorac Surg; 2009 Oct; 88(4):1171-9. PubMed ID: 19766802
[TBL] [Abstract][Full Text] [Related]
17. Construction of tissue-engineered heart valves by using decellularized scaffolds and endothelial progenitor cells.
Fang NT; Xie SZ; Wang SM; Gao HY; Wu CG; Pan LF
Chin Med J (Engl); 2007 Apr; 120(8):696-702. PubMed ID: 17517187
[TBL] [Abstract][Full Text] [Related]
18. Cholesterol-modified polyurethane valve cusps demonstrate blood outgrowth endothelial cell adhesion post-seeding in vitro and in vivo.
Stachelek SJ; Alferiev I; Connolly JM; Sacks M; Hebbel RP; Bianco R; Levy RJ
Ann Thorac Surg; 2006 Jan; 81(1):47-55. PubMed ID: 16368333
[TBL] [Abstract][Full Text] [Related]
19. Coculture of endothelial and smooth muscle cells on a collagen membrane in the development of a small-diameter vascular graft.
Wu HC; Wang TW; Kang PL; Tsuang YH; Sun JS; Lin FH
Biomaterials; 2007 Mar; 28(7):1385-92. PubMed ID: 17141865
[TBL] [Abstract][Full Text] [Related]
20. Seeding of human vascular cells onto small diameter polyurethane vascular grafts.
Gulbins H; Pritisanac A; Dauner M; Petzold R; Goldemund A; Doser M; Meiser B; Reichart B
Thorac Cardiovasc Surg; 2006 Mar; 54(2):102-7. PubMed ID: 16541350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
